Does CYTARABINE Cause Plasma cell myeloma refractory? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Plasma cell myeloma refractory have been filed in association with CYTARABINE (cytarabine). This represents 0.0% of all adverse event reports for CYTARABINE.
13
Reports of Plasma cell myeloma refractory with CYTARABINE
0.0%
of all CYTARABINE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Plasma cell myeloma refractory From CYTARABINE?
Of the 13 reports.
Is Plasma cell myeloma refractory Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CYTARABINE. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does CYTARABINE Cause?
Febrile neutropenia (6,142)
Off label use (4,183)
Pyrexia (2,992)
Neutropenia (2,558)
Disease progression (2,352)
Drug ineffective (2,281)
Thrombocytopenia (2,148)
Sepsis (2,013)
Myelosuppression (1,869)
Product use in unapproved indication (1,619)
What Other Drugs Cause Plasma cell myeloma refractory?
BORTEZOMIB (618)
DEXAMETHASONE (513)
LENALIDOMIDE (489)
DARATUMUMAB (404)
CARFILZOMIB (386)
POMALIDOMIDE (280)
CYCLOPHOSPHAMIDE (237)
IXAZOMIB (132)
DOXORUBICIN (115)
ETOPOSIDE (90)
Which CYTARABINE Alternatives Have Lower Plasma cell myeloma refractory Risk?
CYTARABINE vs CYTARABINE\DAUNORUBICIN
CYTARABINE vs DABIGATRAN
CYTARABINE vs DABIGATRAN ETEXILATE
CYTARABINE vs DABRAFENIB
CYTARABINE vs DABRAFENIB\TRAMETINIB